Cancer Therapy

Cancer treatment system non-invasively focuses heat on drug-injected region

Published in Biotech Business Week, February 13th, 2006

BSD Medical Corp. (BSM) announced that the company is closely monitoring the National Cancer Institute's recent endorsement of a method for treating ovarian cancer, because NCI's newly recommended treatment is currently being researched in combination with therapy provided by BSD's cancer treatment systems.

The purpose of the research underway is to test the ability of BSD's cancer treatment systems to further improve the results from NCI's endorsed method of injecting chemotherapy drugs into the abdomen after surgery to increase the longevity of women suffering from ovarian cancer.

The BSD-2000 cancer treatment system is well designed to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2006-02-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry